C34
Conditions
Interventions
Group 1: Retrospective analysis of blood samples from patients with lung cancer using the detection of volatile organic compounds. The aim of the study is to demonstrate a statistically significant di
Sponsors
PES Technologies Limited
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of lung cancer Diagnosis of COPD
Exclusion criteria
Exclusion criteria: No Consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of the study is to demonstrate a statistically significant difference in sensor signatures between lung cancer samples and healthy control samples. The project is intended solely to provide initial scientific findings and proof of concept. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objectives are to evaluate diagnostic performance (AUROC, sensitivity/specificity) and feasibility (error rates, throughput). | — |
Countries
Germany
Contacts
Public ContactMarc Schneider
Thoraxklinik-Heidelberg
Outcome results
None listed